161 related articles for article (PubMed ID: 38441657)
41. The role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registry.
Husson O; Vissers PA; Denollet J; Mols F
Acta Oncol; 2015 May; 54(5):669-77. PubMed ID: 25752968
[TBL] [Abstract][Full Text] [Related]
42. Depression, Anxiety, and Their Association to Health-Related Quality of Life in Men Commencing Prostate Cancer Treatment at Tertiary Hospitals in Cape Town, South Africa.
Irusen H; Fernandez P; Van der Merwe A; Suliman S; Esterhuizen T; Lazarus J; Parkes J; Seedat S
Cancer Control; 2022; 29():10732748221125561. PubMed ID: 36112984
[TBL] [Abstract][Full Text] [Related]
43. The Influence of Comorbidity on Health-Related Quality of Life After Esophageal Cancer Surgery.
Backemar L; Johar A; Wikman A; Zylstra J; Gossage J; Davies A; Lagergren J; Lagergren P
Ann Surg Oncol; 2020 Aug; 27(8):2637-2645. PubMed ID: 32162078
[TBL] [Abstract][Full Text] [Related]
44. Factors Influencing Global Health Related Quality of Life in Elderly Cancer Patients: Results of a Secondary Data Analysis.
Schmidt H; Nordhausen T; Boese S; Vordermark D; Wheelwright S; Wienke A; Johnson CD
Geriatrics (Basel); 2018 Jan; 3(1):. PubMed ID: 31011053
[TBL] [Abstract][Full Text] [Related]
45. Quality of life in patients with loco-regional rectal cancer after ELRR by TEM versus VLS TME after nChRT: long-term results.
D'Ambrosio G; Picchetto A; Campo S; Palma R; Panetta C; De Laurentis F; La Rocca S; Lezoche E
Surg Endosc; 2019 Mar; 33(3):941-948. PubMed ID: 30421081
[TBL] [Abstract][Full Text] [Related]
46. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.
Ficko SL; Pejsa V; Zadnik V
Radiol Oncol; 2019 Sep; 53(3):337-347. PubMed ID: 31553711
[TBL] [Abstract][Full Text] [Related]
47. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
48. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
49. Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Reijneveld JC; Taphoorn MJB; Coens C; Bromberg JEC; Mason WP; Hoang-Xuan K; Ryan G; Hassel MB; Enting RH; Brandes AA; Wick A; Chinot O; Reni M; Kantor G; Thiessen B; Klein M; Verger E; Borchers C; Hau P; Back M; Smits A; Golfinopoulos V; Gorlia T; Bottomley A; Stupp R; Baumert BG
Lancet Oncol; 2016 Nov; 17(11):1533-1542. PubMed ID: 27686943
[TBL] [Abstract][Full Text] [Related]
50. Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
Dal Lago L; Uwimana AL; Coens C; Vuylsteke P; Curigliano G; Brouwers B; Jagiello-Gruszfeld A; Altintas S; Tryfonidis K; Poncet C; Bottomley A; Sousa B; Brain E; Wildiers H
J Geriatr Oncol; 2022 Jun; 13(5):582-593. PubMed ID: 35101364
[TBL] [Abstract][Full Text] [Related]
51. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
52. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.
D'Ambrosio G; Paganini AM; Balla A; Quaresima S; Ursi P; Bruzzone P; Picchetto A; Mattei FI; Lezoche E
Surg Endosc; 2016 Feb; 30(2):504-511. PubMed ID: 26045097
[TBL] [Abstract][Full Text] [Related]
53. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
54. Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AKC; Tang NLS; Lee KF; Lai PBS; Yu SCH; Yeo W
Cancer Manag Res; 2019; 11():2719-2727. PubMed ID: 31040713
[TBL] [Abstract][Full Text] [Related]
55. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
56. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
57. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
58. Quality of life after laparoscopic vs open sphincter-preserving resection for rectal cancer.
Ng SS; Leung WW; Wong CY; Hon SS; Mak TW; Ngo DK; Lee JF
World J Gastroenterol; 2013 Aug; 19(29):4764-73. PubMed ID: 23922475
[TBL] [Abstract][Full Text] [Related]
59. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
60. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
